Abstract
Th1/Th17-type T-cell responses are upregulated in Behcet’s disease (BD). However, signaling pathways associated with this aberrant immune response are not clarified. Whole-genome microarray profiling was performed with human U133 (Plus 2.0) chips using messenger RNA of isolated CD14+ monocytes and CD4+ T cells from peripheral blood mononucleated cell (PBMC) in patients with BD (n=9) and healthy controls (HCs) (n=9). Flow cytometric analysis of unstimulated (US) and stimulated (phytohaemagglutinin) signal transducer and activator of transcription (STAT3) and pSTAT3 expressions of PBMCs were also analyzed (BD and HC, both n=26). Janus family of kinase (JAK1) was observed to be upregulated in both CD14+ monocytes (1.95-fold) and CD4+ T lymphocytes (1.40-fold) of BD patients. Using canonical pathway enrichment analysis, JAK/STAT signaling was identified as activated in both CD14+ monocytes (P=9.55E−03) and in CD4+ lymphocytes (P=8.13E−04) in BD. Interferon signaling was also prominent among upregulated genes in CD14+ monocytes (P=5.62E−05). Glucocorticoid receptor signaling and interleukin (IL-6) signaling were among the most enriched pathways in differentially expressed genes in CD14+ monocytes (P=2.45E−09 and 1.00E−06, respectively). Basal US total STAT3 expression was significantly higher in BD (1.2 vs 3.45, P<0.05). The JAK1/STAT3 signaling pathway is activated in BD, possibly through the activation of Th1/Th17-type cytokines such as IL-2, interferon (IFN-γ), IL-6, IL-17 and IL-23.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Change history
05 March 2015
This article has been corrected since Advance Online Publication and an erratum is also printed in this issue.
References
Direskeneli H . Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 2006; 45: 1461–1465.
Hughes T, Coit P, Adler A, Yilmaz V, Aksu K, Düzgün N et al. Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease. Nat Genet 2013; 45: 319–324.
Frassanito M, Dammacco R, Cafforio P, Dammacco F . Th1 polarization of the immune response in Behcet's disease. Arthritis Rheum 1999; 42: 1967–1974.
Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol 2005; 139: 371–378.
Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S et al. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 2009; 5: 325–331.
Hreggvidsdottir HS, Noordenbos T, Baeten DL . Inflammatory pathways in spondyloarthritis. Mol Immunol 2014; 57: 28–37.
Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010; 42: 698–702.
Hamzaoui K . Th17 cells in Behcet's disease: a new immunoregulatory axis. Clin Exp Rheumatol 2011; 29: S71–S76.
Direskeneli H, Fujita H, Akdis CA . Regulation of TH17 and regulatory T cells in patients with Behcet disease. J Allergy Clin Immunol 2011; 128: 665–666.
Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 2008; 49: 3058–3064.
Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J Allergy Clin Immunol 2011; 128: 655–664.
Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A et al. Expression of Th-17 and RORgammat mRNA in Behcet's Disease. Med Sci Monit 2011; 17: CR227–CR234.
Liu X, Yang P, Wang C, Li F, Kijlstra A . IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease. Rheumatology (Oxford) 2011; 50: 293–298.
Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M et al. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet's disease. Arthritis Res Ther 2012; 14: R99.
Murray PJ . The JAK-STAT signaling pathway: input and output integration. J Immunol 2007; 178: 2623–2629.
O'Shea JJ, Holland SM, Staudt LM . JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 2013; 368: 161–170.
Coskun M, Salem M, Pedersen J, Nielsen OH . Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res 2013; 76: 1–8.
Xavier JM, Krug T, Davatchi F, Shahram F, Fonseca BV, Jesus G et al. Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behcet's disease susceptibility. J Mol Med (Berl) 2013; 91: 1013–1023.
O'Shea JJ, Plenge R . JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012; 36: 542–550.
Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010; 32: 605–615.
Kim J, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L et al. Imbalance of Th17 to Th1 cells in Behcet's disease. Clin Exp Rheumatol 2010; 28 (4 Suppl 60): S16–S19.
Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S et al. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-gamma in patients with Behcet's disease. Clin Exp Immunol 2012; 168: 68–74.
Na SY, Park MJ, Park S, Lee ES . Up-regulation of Th17 and related cytokines in Behcet's disease corresponding to disease activity. Clin Exp Rheumatol 2013; 31 (3 Suppl 77): 32–40.
Akman-Demir G, Tüzün E, Içöz S, Yeşilot N, Yentür SP, Kürtüncü M et al. Interleukin-6 in neuro-Behcet's disease: association with disease subsets and long-term outcome. Cytokine 2008; 44: 373–376.
Qi J, Tüzün E, Içöz S, Yeşilot N, Yentür SP, Kürtüncü M et al. Increased Notch pathway activation in Behcet's disease. Rheumatology (Oxford) 2014; 44: 373–376.
Yang J, Stark GR . Roles of unphosphorylated STATs in signaling. Cell Res 2008; 18: 443–451.
Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007; 21: 1396–1408.
Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG et al. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem 2012; 287: 14192–14200.
Hou S, Qi J, Zhang Q, Liao D, Li Q, Hu K et al. Genetic variants in the JAK1 gene confer higher risk of Behcet's disease with ocular involvement in Han Chinese. Hum Genet 2013; 132: 1049–1058.
Hu K, Hou S, Jiang Z, Kijlstra A, Yang P . JAK2 and STAT3 polymorphisms in a Han Chinese population with Behcet's disease. Invest Ophthalmol Vis Sci 2012; 53: 538–541.
Cenit MC, Ortego-Centeno N, Raya E, Callejas JL, García-Hernandez FJ, Castillo-Palma MJ, Fernandez-Sueiro JL et al. Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease. Hum Immunol 2013; 74: 230–233.
Oh HM, Ortego-Centeno N, Raya E, Callejas JL, García-Hernandez FJ, Castillo-Palma MJ et al. Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J Immunol 2011; 187: 3338–3346.
Kovacic JC, Gupta R, Lee AC, Ma M, Fang F, Tolbert CN et al. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J Clin Invest 2010; 120: 303–314.
Yeilding N, Szapary P, Brodmerkel C, Benson J, Plotnick M, Zhou H et al. Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives—an update. Ann N Y Acad Sci 2012; 1263: 1–12.
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335: 1078–1080.
R Development Core Team. R: a language and environment for statistical computing 2013 R Foundation for Statistical Computing: Vienna, Austria.
Tusher VG, Tibshirani R, Chu G . Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–5121.
Acknowledgements
This study is supported through grants of Turkish Scientific and Technical Council (TUBITAK, No: 106S320) and Marmara University (BAPKO, SAG-BGS-290107-0022 and SAG-A-090512-0132). JDW and MGD were supported by NIH 5P20GM103636-02.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Genes and Immunity website
Supplementary information
Rights and permissions
About this article
Cite this article
Tulunay, A., Dozmorov, M., Ture-Ozdemir, F. et al. Activation of the JAK/STAT pathway in Behcet’s disease. Genes Immun 16, 170–175 (2015). https://doi.org/10.1038/gene.2014.64
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2014.64
This article is cited by
-
Tofacitinib for the treatment of severe rare skin diseases: a narrative review
European Journal of Clinical Pharmacology (2024)
-
The roles of immune cells in Behçet’s disease
Advances in Rheumatology (2023)
-
Transcriptome analysis of immune cells from Behçet’s syndrome patients: the importance of IL-17-producing cells and antigen-presenting cells in the pathogenesis of Behçet’s syndrome
Arthritis Research & Therapy (2022)
-
Identification of novel genes in Behcet’s disease using integrated bioinformatic analysis
Immunologic Research (2022)
-
Mechanism and biomarkers in aortitis––a review
Journal of Molecular Medicine (2020)